Loading organizations...
Key people at Strategic Investment Fund.
The Strategic Investment Fund (SIF) operates as the impact-first strategic investment arm of the Bill & Melinda Gates Foundation. It deploys financial tools like venture capital, debt, and structured financing to back and scale innovations. SIF focuses on life sciences, agriculture, healthcare, inclusive finance, U.S. education, and women’s innovation, aiming to overcome market obstacles for global development.
Established in 2009 by the Bill & Melinda Gates Foundation, SIF emerged from the insight that investment capital could effectively complement traditional grants. This approach allows the foundation to bridge financing gaps and catalyze sustainable market development where philanthropy alone is insufficient. It fosters both social impact and financial viability.
SIF’s investments support innovators and enterprises developing solutions for underserved populations, improving lives globally. Collaborating with the foundation’s teams, SIF unlocks markets and scales technologies for urgent impact. Its vision integrates strategic investments with philanthropic objectives, driving lasting positive global change.
Key people at Strategic Investment Fund.
Strategic Investment Fund has 2 tracked investments across 2 companies. The latest tracked deal is $450K Other Equity in CalendarHero in August 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 12, 2020 | CalendarHero | $450K Other Equity | BDC Capital, Epstein Enterprises, Perennial, Strategic Investment Fund | — |
| Oct 21, 2010 | Abionyx Pharma | $14.0M Series C | Irdi Capital Investissement | Alta Partners, Daiwa Corporate Investment, EDF Ventures, HealthCap, OrbiMed, Sofinnova Partners, TVM Capital |